11 Sep 2025

Quick take | Washington’s fear of Chinese biotech could be just what Beijing needs

Subscribe to keep reading.

Trivium Tech keeps you briefed on the latest developments in China tech policy.

Try it free

Already a subscriber? Log in.

The Trump administration is considering an executive order (E.O.) that would block US pharma companies from buying Chinese-developed drug candidates. Per the New York Times:

“At the heart of the possible clampdown is a drafted executive order that threatens to cut off the pipeline of Chinese-inven...